In brief: Avara acquires manufacturing facility from AZ

In brief: Avara acquires manufacturing facility from AZ
Timothy Tyson

Avara Pharmaceutical Services is to acquire a French manufacturing and distribution facility after signing an agreement with AstraZeneca.

Avara Pharmaceutical Services is a contract manufacturing and technical services organisation providing both API formulation and manufacturing.

The company now has eight sites – three in the US, including the corporate HQ’s; one in Puerto Rico; one in the UK; one in Ireland; one in Italy and this new additional site in France.

“With rapid expansion and integration set for 2017-2018, we continue, with great confidence, to build a pharmaceutical services company with complementary offerings in key regions to serve the rapidly growing market,” said Chairman and CEO Timothy Tyson